AcuFocus Announces FDA Approval for the IC-8® Apthera™ Intraocular Lens, the First and Only Small Aperture Lens for Cataract Surgery

IRVINE, Calif.--(BUSINESS WIRE)--AcuFocus, Inc., a privately held ophthalmic medical device company, today announced U.S. Food and Drug Administration (FDA) approval for its breakthrough IC-8® Apthera™ intraocular lens (IOL) for the treatment of cataracts. The Apthera IOL is the first and only non-toric extended depth of focus IOL approved for the 82% of cataract patients who have as much as 1.5 diopters (D) of corneal astigmatism.2 “We are delighted to receive FDA approval for our first-of-its